From Big Pharma to the cannabis industry: Q&A with PharmaCann’s Chris Diorio

Omar Sacirbey  | March 28, 2017

By Omar Sacirbey

If marijuana business entrepreneurs are wondering whether pharmaceutical professionals might be interested in jumping over to cannabis, the answer is a resounding yes.

Take Chris Diorio, a 25-year pharma industry veteran who recently made such a move, becoming director of research and development for PharmaCann of New York.

Omar Sacirbey  |
March 28, 2017

Chart: 8 new marijuana markets slated to launch in 2018

Eli McVey  | March 27, 2017

By Eli McVey

Get ready for the next iteration of the green rush.

The marijuana industry is poised to grow by leaps and bounds in 2018, when at least eight of the 11 states that passed significant medical or recreational cannabis measures last year are expected to start sales.

Eli McVey  |
March 27, 2017

By John Schroyer and Omar Sacirbey

New York tweaks its medical marijuana program, a Rhode Island MMJ committee meets eight years after its formation, and a new cannabis advocacy group is born.

Here’s a closer look at some notable developments in the marijuana industry over the past week.

John Schroyer  |
March 24, 2017

Industry officials encouraged as Florida’s medical cannabis law takes shape

Omar Sacirbey  | March 23, 2017

By Omar Sacirbey

After months of uncertainty, Florida’s new medical marijuana program is starting to come together and industry officials believe the number of MMJ business licenses will be expanded beyond the seven companies currently licensed under the state’s CBD-focused program.

Omar Sacirbey  |
March 23, 2017

Court-appointed receivers an option for troubled marijuana companies

John Schroyer  | March 22, 2017

By John Schroyer

Business partnerships in the cannabis industry have become increasingly common. But what happens when such a partnership goes down the tubes and the parties wind up in court?

In that situation, who’s left to run day-to-day operations?

John Schroyer  |
March 22, 2017

What’s in a strain name? Q&A with Canndescent CEO Adrian Sedlin

Bart Schaneman  | March 21, 2017

By Bart Schaneman

Walk into any marijuana outlet and you'll find jars of flower strains with names like Golden Goat, Ghost Train Haze or Robert Plant.

Such names convey minimal information to novice consumers, forcing them to do further research before they can purchase any cannabis. California-based cultivator Canndescent is trying to simplify that experience.

Bart Schaneman  |
March 21, 2017

Chart: Licensing bottlenecks hamper growth of Massachusetts MMJ program

Eli McVey  | March 20, 2017

By Eli McVey

Still reeling from a sluggish start statewide, Massachusetts’ medical marijuana program also is hindered by local-level licensing bottlenecks that have allowed just a handful of dispensaries to open to serve nearly 35,000 MMJ patients throughout the state.

Eli McVey  |
March 20, 2017